In this Issue:
Dasatinib dose optimisation avoids pleural effusion
Azacitidine in newly diagnosed elderly AML patients
Novel therapies in relapsed CLL
HSCT survival outcomes by donor transplantation
Survival of haploidentical HSCT vs chemotherapy alone in ALL
Exploring nilotinib-induced vasculopathy in CML
Ruxolitinib vs best available care in polycythaemia vera
Impact of bleomycin and dacarbazine within the ABVD regimen
Salvage regimens compared in primary refractory AML
Blinatumomab active in relapsed/refractory ALL
Low-dose thalidomide improves epistaxis in HHT
Please login below to download this issue (PDF)